Stock Market Today: IOL Chemicals and Pharmaceuticals Limited share price gained more than 5% during the intraday trades on Monday after it had announced 1:5 stock split. The announcement by IOL chemcials was made post market hours on Friday
IOL Chemicals and Pharmaceutical share price opened at ₹415.70 on the BSE on Monday, more than 2% higher than its previous close of ₹409.95. The IOL Chemicals and Pharmaceutical share price thereafter went to gain more than 5% to intraday highs of ₹431.35.
The IOL Chemicals and Pharmaceutical share price having more that 140% in last 5 years have given handsome returns and is a Multibagger stock for investors.
IOL Chemicals and Pharmaceutical on Friday announced that the Board of Directors of the Company, at its meeting held on 27th December 2024, has approved, the sub-division or split of each equity share of face value of Rs. 10/- (Rupees Ten only) each, fully paid-up into 5 (Five) equity shares of face value of Rs. 2/- (Rupee two only) each, fully paid-up, by alteration of Capital Clause of the Memorandum of Association of the Company.
The proposed sub-division or split is subject to the approval of the Shareholders through Postal Ballot process. The Record Date for determining eligibility for the sub-division or split thereby is not decides and will be communicated in due course, sadi the company in its speech on the exchange.
Besides the delay in filling the vacancy of the Woman Independent Director and composition of the Nomination and Remuneration Committe and also the fines imposed by BSE and NSE vide their letters dated 21st November 2024, were presented to the Board of Directors during their meeting held on 27th December 2024.
The Board, as per the company release after careful analysis and deliberation, acknowledged that the delay in meeting the compliance requirements was inadvertent and unintentional.
Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before taking any investment decisions.
